The Lateral Metalation of Isoxazolo[3,4-d]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors

Isoxazolo[3,4-d] pyridazinones ([3,4-d]s) were previously shown to have selective positive modulation at the metabotropic glutamate receptor (mGluR) Subtypes 2 and 4, with no functional cross-reactivity at mGluR1a, mGluR5, or mGluR8. Additional analogs were prepared to access more of the allosteric pocket and achieve higher binding affinity, as suggested by homology modeling. Two different sets of analogs were generated. One uses the fully formed [3,4-d] with an N6-aryl with and without halogens. These underwent successful selective lateral metalation and electrophilic quenching (LM&EQ) at the C3 of the isoxazole. In a second set of analogs, a phenyl group was introduced at the C4 position of the [3,4-d] ring via a condensation of 4-phenylacetyl-3-ethoxcarbonyl-5-methyl isoxazole with the corresponding hydrazine to generate the 3,4-ds 2b and 2j to 2n.

[1]  Suwen Zhao,et al.  G protein-coupled receptors: structure- and function-based drug discovery , 2021, Signal Transduction and Targeted Therapy.

[2]  S. Cuzzocrea,et al.  Role of Metabotropic Glutamate Receptors in Neurological Disorders , 2019, Front. Mol. Neurosci..

[3]  Julie L. Engers,et al.  Discovery of VU2957 (Valiglurax): An mGlu4 Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's Disease. , 2018, ACS medicinal chemistry letters.

[4]  D. Backos,et al.  Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4. , 2018, Bioorganic & medicinal chemistry.

[5]  Sun Choi,et al.  Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design , 2018, Front. Pharmacol..

[6]  U. Grohmann,et al.  Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 , 2018, Expert opinion on drug discovery.

[7]  K. Gregory,et al.  Molecular insights into allosteric modulation of Class C G protein-coupled receptors. , 2017, Pharmacological research.

[8]  David E. Gloriam,et al.  Structural insight to mutation effects uncover a common allosteric site in class C GPCRs , 2016, Bioinform..

[9]  K. Gregory,et al.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors. , 2016, Chemical reviews.

[10]  Julie L. Engers,et al.  Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents. , 2015, Journal of medicinal chemistry.

[11]  Zhiwei Feng,et al.  Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family , 2015, The AAPS Journal.

[12]  Paul J. Harrison,et al.  The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2−/−, GRM3−/− and GRM2/3−/− knockout mice , 2015, Neuropharmacology.

[13]  N. Garg,et al.  Pyridynes and indolynes as building blocks for functionalized heterocycles and natural products. , 2015, Chemical communications.

[14]  J. Giraldo,et al.  Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  Jens Meiler,et al.  Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders , 2014, Nature Reviews Drug Discovery.

[16]  R. Stevens,et al.  Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator , 2014, Science.

[17]  C. Campana,et al.  3-(1,3-Diphenylpropan-2-yl)-4-methyl-6-phenylisoxazolo[3,4-d]pyridazin-7(6H)-one , 2013, Acta crystallographica. Section E, Structure reports online.

[18]  G. Fisone,et al.  Group III and subtype 4 metabotropic glutamate receptor agonists: Discovery and pathophysiological applications in Parkinson's disease , 2013, Neuropharmacology.

[19]  Marvin Waldman,et al.  Lions and tigers and bears, oh my! Three barriers to progress in computer-aided molecular design , 2011, Journal of Computer-Aided Molecular Design.

[20]  A. Scilimati,et al.  Synthesis of N,N-dialkylaminobenzonitriles and halo-(N,N-dialkyl)benzamidines by reaction of halobenzonitriles with lithium amides , 2011 .

[21]  A. Robichaud,et al.  Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeutics. , 2011, ACS chemical neuroscience.

[22]  Dan S. Tawfik,et al.  Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series. , 2010, Journal of molecular biology.

[23]  P. Conn,et al.  Metabotropic glutamate receptors: physiology, pharmacology, and disease. , 2010, Annual review of pharmacology and toxicology.

[24]  C. Vergelli,et al.  Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. , 2009, Journal of medicinal chemistry.

[25]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[26]  A. Scilimati,et al.  Effect of the aryl group substituent in the dimerization of 3-arylisoxazoles to syn 2,6-diaryl-3,7-diazatricyclo[4.2.0.02,5]octan-4,8-diones induced by LDA , 2008 .

[27]  Lisa Yan,et al.  Fully Automated Molecular Mechanics Based Induced Fit Protein-Ligand Docking Method , 2008, J. Chem. Inf. Model..

[28]  Eric A. Althoff,et al.  Kemp elimination catalysts by computational enzyme design , 2008, Nature.

[29]  C. Ghelardini,et al.  4-amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action. , 2007, Journal of medicinal chemistry.

[30]  C. Vergelli,et al.  Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity as potential agents for treatment of erectile dysfunction. , 2006, Journal of medicinal chemistry.

[31]  N. R. Natale,et al.  Catalytic asymmetric synthesis of glutamate analogues. , 2004, Organic letters.

[32]  Mei Bai,et al.  Dimerization of G-protein-coupled receptors: roles in signal transduction. , 2004, Cellular signalling.

[33]  M. Scheideler,et al.  4-Amino-3(2H)-pyridazinones bearing arylpiperazinylalkyl groups and related compounds: synthesis and antinociceptive activity. , 2003, Farmaco.

[34]  C. Ghelardini,et al.  [(3-Chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents. , 2003, Journal of medicinal chemistry.

[35]  David A. Case,et al.  Effective Born radii in the generalized Born approximation: The importance of being perfect , 2002, J. Comput. Chem..

[36]  M. C. Castellana,et al.  Isoxazolo[3,4-d]pyridazinones and analogues as Leishmania mexicana PDE inhibitors. , 2002, Farmaco.

[37]  V. D. Piaz,et al.  Synthesis and Evaluation of Some Pyrazolo[3,4-d]pyridazinones and Analogues as PDE 5 Inhibitors Potentially Useful as Peripheral Vasodilator Agents , 2002, Journal of enzyme inhibition and medicinal chemistry.

[38]  B. Twamley,et al.  An improved procedure for the lateral lithiation of ethyl 4-acetyl-5-methyl-3-isoxazolyl carboxylate ☆ , 2001 .

[39]  F. Fanelli,et al.  Phenylpiperazinylalkylamino substituted pyridazinones as potent alpha(1) adrenoceptor antagonists. , 2001, Journal of medicinal chemistry.

[40]  G. Rastelli,et al.  Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors. , 1999, Journal of medicinal chemistry.

[41]  N. R. Natale,et al.  Lateral lithiation of ethyl 4-acetyl-5-methyl-3-isoxazolyl carboxylate with 5,5-dimethyl-1,3-dioxanyl as a directing group , 1998 .

[42]  F. Fanelli,et al.  Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies. , 1998, Bioorganic & medicinal chemistry.

[43]  Y. Mirzaei,et al.  The Lateral Metalation of Isoxazoles. A Review. , 1995 .

[44]  Y. Mirzaei,et al.  THE LATERAL METALATION OF ISOXAZOLES. A REVIEW , 1993 .

[45]  T. Torroba,et al.  Solid State Photodimerization Reaction of Some 3‐Styrylisoxazolo‐(3,4‐d)pyridazin‐7(6H)‐ones. , 1987 .

[46]  H. Hope,et al.  Metalation of isoxazolyloxazolines, a facile route to functionally complex isoxazoles: utility, scope, and comparison to dianion methodology , 1985 .

[47]  V. D. Piaz,et al.  New functionalized pyrazoles from isoxazolopyridazinones , 1985 .

[48]  C. Niou,et al.  A facile synthesis of functionally complex isoxazole derivatives , 1985 .

[49]  S. Pinzauti,et al.  Condensation of some 3‐methylisoxazolo[3,4‐d]pyridazin‐7(6H)ones with aromatic aldehydes , 1976 .

[50]  D. Kemp,et al.  Physical organic chemistry of benzisoxazoles. II. Linearity of the Broensted free energy relation for the base-catalyzed decomposition of benzisoxazoles , 1973 .

[51]  D. Kemp,et al.  Physical organic chemistry of benzisoxazoles. I. Mechanism of the base-catalyzed decomposition of benzisoxazoles , 1973 .

[52]  R. Micetich,et al.  Studies in isoxazole chemistry. III. The preparation and lithiation of 3,5-disubstituted isoxazoles , 1970 .

[53]  John D. Roberts,et al.  Rearrangement in the Reaction of Chlorobenzene-1-C^(14) with Potassium Amide , 1953 .

[54]  David E. Gloriam,et al.  Generic GPCR residue numbers - aligning topology maps while minding the gaps. , 2015, Trends in pharmacological sciences.

[55]  Ajay N. Jain,et al.  Does your model weigh the same as a Duck? , 2011, Journal of Computer-Aided Molecular Design.

[56]  Arthur Christopoulos,et al.  Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders , 2009, Nature Reviews Drug Discovery.

[57]  V. D. Piaz,et al.  4,5-Functionalized 6-phenyl-3(2H)-pyridazinones: synthesis and evaluation of antinociceptive activity , 1996 .

[58]  T. Torroba,et al.  Solid State Photodimerisation Reaction of Some 3-Styrylisoxazolo[3,4-d]pyrida-zin-7(6H)-ones , 1986 .

[59]  C. Niou,et al.  Synthesis, metalation and electrophilic quenching of alkyl-isoxazole-4-tertiary carboxamides: a critical comparison of three isoxazole lateral metalation methods , 1986 .

[60]  V. D. Piaz,et al.  1,2,3,4-Tetrahydro-1,2-diazepine derivatives from isoxazolo[3,4-d]pyridazin-7(6H)-ones , 1984 .